ReNeuron Spies SPA and RMAT For Stem Cell Stroke Therapy

 
• By Alexandra Shimmings

UK cell therapeutics firm ReNeuron has released its late-stage development strategy for its novel stem cell therapy for stroke disability, CTX.

More from Business

More from Scrip